Ian C. Gilchrist MD, FACC, FSCAI, FCCM, FAHA

Dr. Gilchrist has been active in >150 multi-centered clinical trials over the last 20 years. These have included many of the pivotal trials of thrombolytic therapy, antiplatelet and antithrombin agents that define standard and future care in interventional cardiology.